J0219
HCPCSInj aval alfa-nqpt 4mg
Official HCPCS Level II long descriptor
Injection, avalglucosidase alfa-ngpt, 4 mg
HCPCS Level II code J0219 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj aval alfa-nqpt 4mg
Added to HCPCS: 2022-04-01
Nearby codes in J0
- J0207Amifostine
- J0208Inj, pedmark, 100 mg
- J0209Inj, sod thiosulfate (hope)
- J0210Methyldopate hcl injection
- J0211Inj, nithiodote, 3mg / 125mg
- J0216Inj, alfentanil hcl, 500mcg
- J0217Inj velmanase alfa-tycv 1 mg
- J0218Inj olipudase alfa-rpcp 1mg
- J0220Alglucosidase alfa injection
- J0221Lumizyme injection
- J0222Inj., patisiran, 0.1 mg
- J0223Inj givosiran 0.5 mg
- J0224Inj. lumasiran, 0.5 mg
- J0225Inj, vutrisiran, 1 mg
- J0248Inj, remdesivir, 1 mg
- J0256Alpha 1 proteinase inhibitor
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.